Who owns Cyclacel Pharmaceuticals Inc?
- Ticker: BGMS
- CUSIP Number: 23254l876
Tip: Access positions for across all investors
Analyze quarterly positions in Cyclacel Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cyclacel Pharmaceuticals stock
Who bought or sold Cyclacel Pharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citadel Advisors | 75k | $69k | 241% | Jun 2026 |
|
| Jane Street | 16k | $15k | 100% | Jun 2026 |
|
| Tower Research Capital | 5.7k | $5.2k | 34% | Jun 2026 |
|
| UBS Group | 4.3k | $3.9k | 100% | Jun 2026 |
|
| SBI Securities | 701.00 | $637.980100 | 40% | Jun 2026 |
|
| Advisor Group Holdings | 1.00 | $0 | 0% | Jun 2026 |
|
| Archer Investment Corp | 1.00 | $1.000000 | 0% | Jun 2026 |
|
Who sold out of Cyclacel Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Renaissance Technologies | Mar 2026 | 46k | $46k |
| XTX Topco | Mar 2026 | 22k | $22k |
| Geode Capital Management | Mar 2026 | 22k | $22k |